Clinical Trial: Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: A Non-interventional, Non-controlled, Post-marketing Study to Obtain Knowledge of the Safety of ZyComb® (Xylometazoline Hydrochloride 0.5 mg/mL and Ipratropium Bromide 0.6 mg/mL) for Symptoms of
Brief Summary: The objectives of the study are to obtain knowledge about the safety in use, the patients' general impression of the treatment and the pattern of use of ZyComb® in an over-the-counter (OTC) setting.
Detailed Summary:
Sponsor: Nycomed
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Nycomed
Dates:
Date Received: May 24, 2007
Date Started: December 2006
Date Completion:
Last Updated: May 4, 2012
Last Verified: February 2008